Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05757076 · ClinicalTrials.gov registry record
Aldosterone Renin Ratio (ARR) Test to Increase Case-detection of Primary Aldosteronism (PA)
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 53
- Enrollment target
NCT05757076 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 53 participants.
The verdict
NCT05757076 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
The mission of this project is to increase the detection of Primary Aldosteronism (PA), the most common cause of secondary hypertension, which can either be cured surgically or treated with targeted medications.
Interventions
- PROCEDURE Blood test for ARR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2023-05-02 |
| Est. Completion | 2025-12-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05757076
The ClinicalTrials.gov registry entry for NCT05757076 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood test for ARR is the first listed.
NCT05757076 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05757076 about?
NCT05757076 is a clinical study titled "Aldosterone Renin Ratio (ARR) Test to Increase Case-detection of Primary Aldosteronism (PA)". The mission of this project is to increase the detection of Primary Aldosteronism (PA), the most common cause of secondary hypertension, which can either be cured surgically or treated with targeted medications.
What is the current status of trial NCT05757076?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2023-05-02. Estimated completion is 2025-12-29.
What interventions are being tested in trial NCT05757076?
The interventions under investigation include: Blood test for ARR (PROCEDURE).
Who is sponsoring clinical trial NCT05757076?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.